Home Contact
Login   |  Tell a Friend
Financial Optimization through Technology Innovation
mutual fund
 Top Fund Managers
Latest Mutual Fund News Latest Mutual Fund News

Financial Advisor Sponsor:Dean L. Boebinger


 Bookmark this site!
Follow FundMojo on Twitter
Get Fund Information

Get Stock News

(Enter Stock Symbol)

Partner Sites

Annuities
Wall Street Journal
eHealthInsurance
Fund Mojo on Facebook
Fund Mojo help you discover the best fund managers, funds, and related information

Fund Intelligence | Best Managers | MAHCX Insights | MAHCX Score | MAHCX Performance | MAHCX Manager | MAHCX News | MAHCX Allocation | MAHCX Holdings Change

Mutual Fund Insights: BlackRock Healthcare Instl Fund (MAHCX)

In-depth Analysis of BlackRock Healthcare Instl Fund (MAHCX)

Mutual fund chart: BlackRock Healthcare Instl Fund (MAHCX)

3 months
6 months
1 year
3 year
5 year

See BlackRock Healthcare Instl Fund (MAHCX) performance details as of January 31, 2010

  

    Last Trade: $6.50 on 3/17/2010, Change: -0.01 (-0.15%)

  

Fund Manager - Robert C. Hodgson

Fund Manager Tenure: 12.2 years
Fundmojo Fund Grade: A (Score: 0.71)     (What does this score mean?)
Hodgson has been a director of BlackRock, Inc. since 2006, was a director of MLIM from 1998 to 2006, was vice president of MLIM from 1997 to 1998 and was a portfolio manager in the equity management group of MLIM from 1997 to 2006.  Get more insights on Robert C. Hodgson

  

What we like about BlackRock Healthcare Instl Fund (MAHCX) What we like about BlackRock Healthcare Instl Fund (MAHCX)

Data for BlackRock Healthcare Instl Fund (MAHCX) as of January 31, 2010

  • BlackRock Healthcare Instl Fund (MAHCX) management has been with BlackRock Healthcare Instl Fund for 12.2 years
  • BlackRock Healthcare Instl Fund (MAHCX) has good mid-term performance (3-year return 1.33% vs -0.24% Health category average)
  • BlackRock Healthcare Instl Fund (MAHCX) has good Long-term performance (5-year return 5.05% vs 4.22% Health category average)
  • BlackRock Healthcare Instl Fund (MAHCX) ratio of up-years vs down years is greater than 2
  • BlackRock Healthcare Instl Fund (MAHCX) has a Morningstar rating of 4 and above
  • BlackRock Healthcare Instl Fund (MAHCX) is less volatile than its peers as it has a 3-year Standard Deviation of 17.31, lower than category average of 18.84
  • BlackRock Healthcare Instl Fund (MAHCX) has a lower management fee than its Health average: 1.35% vs 1.91%
  • BlackRock Healthcare Instl Fund (MAHCX) is a true no-load fund as it has no load and no 12b1 promotion, distributions, marketing expenses

  

What we are cautious about BlackRock Healthcare Instl Fund (MAHCX) What we are cautious about BlackRock Healthcare Instl Fund (MAHCX)

Data for BlackRock Healthcare Instl Fund (MAHCX) as of January 31, 2010

  • BlackRock Healthcare Instl Fund is a focused fund with 53.62% of the portfolio on top 10 securities. This tends to produce more volatility compared to a diversified fund. See fund top 10 holdings.
  • BlackRock Healthcare Instl Fund (MAHCX) has a less-than-ideal short-term performance (1-year return 23.43% vs 24.07% Health category average)
See BlackRock Healthcare Instl Fund (MAHCX) performance details as of January 31, 2010

  

  

Interested in other top mutual funds in similar Health category?

Below are some additional Health mutual funds generated out of our database

  

BlackRock Healthcare Instl Fund (MAHCX) Net Asset

Track net asset change of BlackRock Healthcare Instl fund (MAHCX)

DateNet Asset
01/2010$107.65M
11/2009$106.29M
10/2009$101.22M
More historic net asset information on BlackRock Healthcare Instl Fund (MAHCX)

  

BlackRock Healthcare Instl Fund (MAHCX) Portfolio Allocation

Track portfolio allocation change of BlackRock Healthcare Instl fund (MAHCX)

DateCashStockBondOther
07/20096.65%93.35%0%0%
04/20097.5%91.49%0%1.01%
12/20084.05%95.96%0%0%
Click here to see more historic asset allocation information on BlackRock Healthcare Instl Fund (MAHCX)

  

Most Recent Top 10 Holdings in BlackRock Healthcare Instl Fund (MAHCX)

Discover what BlackRock Healthcare Instl Fund (MAHCX) manager is buying

31-Jul-09
Celgene Corporation [8.34%]
Blackrock Liquidity Series, Llc Money Ma [7.11%]
HLTH Corporation [6.67%]
Gilead Sciences, Inc. [6.49%]
Genzyme Corporation [4.84%]
Express Scripts, Inc. [4.83%]
MEDCOHEALTH SOLUTNS [3.97%]
Vertex Pharmaceuticals Incorpor [3.84%]
Masimo Corporation [3.8%]
BAXTER INTL INC [3.73%]

30-Apr-09
Blackrock Liquidity Series, Llc Money Ma [8.14%]
Gilead Sciences, Inc. [6.37%]
Celgene Corporation [6.04%]
HLTH Corporation [5.49%]
Genzyme Corporation [5.18%]
Express Scripts, Inc. [4.72%]
Masimo Corporation [4.26%]
Genoptix, Inc. [3.8%]
[3.79%]
Cephalon, Inc. [3.74%]

31-Dec-08
Genentech, Inc. [9.75%]
BRISTOL MYERS SQIBB [6.46%]
Celgene Corporation [5.32%]
HLTH Corporation [5.04%]
Genzyme Corporation [4.79%]
Genoptix, Inc. [4.78%]
Gilead Sciences, Inc. [4.55%]
ABBOTT LABORATORIES [3.77%]
Teva Pharmaceutical Industries Ltd [3.53%]
Masimo Corporation [3.44%]
Click here for Stock Holding Change Map in BlackRock Healthcare Instl Fund (MAHCX)

  

Related books and products to BlackRock Healthcare Instl Fund (MAHCX)

  

Latest News on BlackRock Healthcare Instl (MAHCX)

See what is happening with BlackRock Healthcare Instl Fund (MAHCX)

 

Books and Resources

 

 

See more information on BlackRock Healthcare Instl Fund (MAHCX)